Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease-Reference-Cited by-同舟云学术

Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease

Published:2007-12 Issue:6 Volume:154 Page:1043-1051
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Hlatky Mark A.,Ashley Euan,Quertermous Thomas,Boothroyd Derek B.,Ridker Paul,Southwick Audrey,Myers Richard M.,Iribarren Carlos,Fortmann Stephen P.,Go Alan S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry;Visse;Circ Res,2003

2. Matrix metalloproteinases in vascular remodeling and atherogenesis. The good, the bad, and the ugly;Galis;Circ Res,2002

3. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease;Tayebjee;Am J Cardiol,2005

4. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease;Zeng;Intern Med J,2005

5. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes;Kai;J Am Coll Cardiol,1998

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitor dapagliflozin alleviates intramyocardial hemorrhage and adverse ventricular remodeling via suppressing hepcidin in myocardial ischemia-reperfusion injury;European Journal of Pharmacology;2023-07

2. Current Smoking Determines the Levels of Circulating MPO and MMP-9 in Adults with Coronary Artery Disease and Obstructive Sleep Apnea;Journal of Clinical Medicine;2023-06-14

3. Association of inflammation, destruction and angiogenesis genes polymorphism with serum levels of matrix metalloproteinases 3 and 9 in patients with coronary atherosclerosis;2022 Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB);2022-07-07

4. Elevated serum matrix metalloproteinase-2 levels in heart failure patients with reduced ejection fraction and Cheyne-Stokes respiration;Journal of Clinical Sleep Medicine;2022-05

5. Matrix Metalloproteinases and Their Role in Mechanisms Underlying Effects of Quercetin on Heart Function in Aged Zucker Diabetic Fatty Rats;International Journal of Molecular Sciences;2021-04-24